If your organization or health plan paid for the prescription medication Stelara, you may be eligible to recover costs through a recent class action settlement. This legal resolution addresses allegations that the manufacturers of Stelara engaged in practices that delayed the availability of lower-cost generic versions of the drug. Understanding how to navigate the settlement process is essential for third-party payers looking to recoup their losses.
What Is the Stelara Third-Party Payer Settlement?
The Stelara settlement is the result of a legal battle involving Janssen Biotech and Johnson & Johnson. The lawsuits alleged that these companies violated antitrust laws by preventing competition from biosimilar or generic versions of the drug. Because generic competition typically drives prices down, the delay meant that insurers and health plans paid more for the medication than they would have in a competitive market.
By reaching a settlement, the defendants do not admit to any wrongdoing, but they have agreed to establish a significant fund to compensate those affected. This fund is specifically designated for “Third-Party Payers” (TPPs) who bore the financial burden of the high medication costs during the specified period.
Determining If You Are Eligible
It is important to distinguish between individual patients and third-party payers. This specific class action settlement is generally aimed at entities rather than individual consumers. To qualify as a class member, your organization must fall into one of the following categories:
- Self-Funded Health Plans: Employers or organizations that pay for their employees’ healthcare costs directly.
- Insurance Companies: Private insurers that provide health coverage and paid for Stelara prescriptions.
- Health and Welfare Funds: Labor union funds or other trust funds that provide medical benefits to members.
- Managed Care Organizations: Entities that manage healthcare delivery and costs for a specific population.
Generally, the settlement covers purchases made within a specific timeframe, often referred to as the “Class Period.” If your organization paid or provided reimbursement for Stelara (ustekinumab) for use by your members or employees during this time, you are likely eligible to participate.
Steps to File Your Claim
Filing a claim for a complex pharmaceutical settlement requires attention to detail and organized record-keeping. Follow these steps to ensure your claim is processed correctly:
1. Locate the Official Settlement Portal
The court appoints a third-party administrator to handle the distribution of funds. You must visit the official settlement website to access the necessary forms. While many websites may discuss the case, only the court-authorized portal can accept your official claim submission.
2. Gather Your Purchase Data
To receive a payout, you must prove that your organization actually paid for the medication. You will need to compile data including the National Drug Codes (NDCs) for Stelara, the dates of purchase, and the total amount paid or reimbursed. Most organizations work with their Pharmacy Benefit Manager (PBM) to extract this data efficiently.
3. Complete the Proof of Claim Form
The Proof of Claim and Release form is the primary document you must submit. This form asks for your organization’s tax identification number, contact information, and a summary of the purchase data you gathered. You must sign this document under penalty of perjury to certify its accuracy.
4. Submit by the Deadline
Every class action has a strict deadline for filing claims. If you miss this date, you will lose your right to any portion of the settlement fund. You can typically submit these forms electronically through the administrator’s portal or via traditional mail. Electronic submission is recommended for faster processing and immediate confirmation.
What Documentation Is Required?
While some small claims may be accepted based on a summary of data, larger claims often require supporting documentation. The settlement administrator may request specific records to verify your claim. Be prepared to provide:
- Pharmacy benefit reports showing Stelara transactions.
- Invoices or payment receipts.
- Documentation confirming your status as a self-funded plan or insurer.
- Documentation of any “opt-out” or “carve-out” agreements that might affect your eligibility.
How Much Can You Expect to Receive?
The amount each organization receives depends on several variables. There is no fixed “per-pill” amount. Instead, the total settlement fund is divided among all valid claimants based on their proportional share of the total Stelara spend recorded by the entire class.
Factors that influence your final payout include the total number of valid claims filed and the total dollar amount of Stelara purchases you can prove. Once all claims are verified and the court grants final approval to the settlement, the administrator will begin distributing checks.
Important Deadlines and Hearings
There are several key dates you should mark on your calendar. Beyond the filing deadline, there is usually a “Fairness Hearing.” This is a court session where the judge determines if the settlement is fair, reasonable, and adequate. Class members have the right to attend this hearing or file an objection if they believe the terms are unfair, though this is uncommon for most participants.
If you do nothing, you will not receive any money, and you will give up your right to sue the defendants for these specific claims in the future. Therefore, it is in your organization’s best interest to either file a claim or formally opt out if you intend to pursue your own private lawsuit.
Conclusion
Participating in the Stelara third-party payer settlement is a vital step for health plans and insurers to recover unnecessary costs. By following the filing requirements and meeting the necessary deadlines, your organization can claim its rightful share of the settlement fund. If you found this guide helpful, consider exploring our other articles on navigating legal claims and managing healthcare costs to stay informed on similar opportunities for your organization.